Detailed Narrative
Record-Breaking Q1 Performance
CME Group reported its highest-ever quarterly revenue exceeding $1.6 billion, a 10% increase from Q1 2024. This was accompanied by record average daily volume (ADV) of 29.8 million contracts, up 13% year-over-year, with all six asset classes contributing to growth. Adjusted net income reached $1 billion, and adjusted diluted EPS hit $2.80, both up 12% from the prior year.
International Expansion and Retail Engagement
The international business achieved a record 8.8 million contracts per day, growing 19% year-over-year, with strong performance in EMEA and APAC. Retail segment revenue increased by 10%, with new client acquisition surging 44% to over 83,000 new traders and total participation reaching over 350,000 globally. Micro products, including micro equities, metals, and cryptocurrencies, saw 13% ADV growth to 3.8 million.
Market Data Growth and Pricing
Market Data revenue reached a record $195 million, up 11% year-over-year, driven by a 3.5% pricing increase effective January 1 and strong subscriber growth, particularly from professional and non-professional (retail) users. Non-recurring📎 audit-related revenue contributed approximately $3.5 million, though these are difficult to predict📌.
Risk Management and System Resiliency
Amidst heightened volatility, CME Group proactively increased margin requirements, collecting a record $32 billion in mark-to-market cash on April 9, far exceeding the previous record of $22 billion. The systems demonstrated resilience, handling record order entry volumes exceeding 13 billion messages during the week of April 7 without disruption.
Commodities Strength and Global Benchmarks
The commodities complex (ags, energy, metals) delivered a record first-quarter revenue, following a record year in 2024 with nearly $1.7 billion in revenue. Energy volumes grew 20% in Q1, with April seeing 39% growth, driven by global adoption of WTI and Henry Hub as benchmarks due to the U.S.'s role as a major exporter. Ags business also saw record ADV and open interest, with options open interest reaching 5.1 million contracts.
Capital Allocation and OSTTRA Divestiture
CME Group announced the sale of its 50% stake in the OSTTRA joint venture with S&P Global for $3.1 billion. The company expects to receive half of the proceeds, with the transaction anticipated to close in approximately six months, pending regulatory review. OSTTRA contributed $89 million in earnings to CME in 2024.